Advertisement
Research Article

Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis

  • Yumiko Wada mail,

    ywada@syntapharma.com

    Affiliation: Synta Pharmaceuticals Corp, Lexington, Massachusetts, United States of America

    X
  • Irma Cardinale,

    Affiliation: Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, United States of America

    X
  • Artemis Khatcherian,

    Affiliation: Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, United States of America

    X
  • John Chu,

    Affiliation: Synta Pharmaceuticals Corp, Lexington, Massachusetts, United States of America

    X
  • Aaron B. Kantor,

    Affiliation: Biomarker Discovery Sciences, Pharmaceutical Product Development Inc., Menlo Park, California, United States of America

    X
  • Alice B. Gottlieb,

    Affiliation: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts, United States of America

    X
  • Noriaki Tatsuta,

    Affiliation: Synta Pharmaceuticals Corp, Lexington, Massachusetts, United States of America

    X
  • Eric Jacobson,

    Affiliation: Synta Pharmaceuticals Corp, Lexington, Massachusetts, United States of America

    X
  • James Barsoum,

    Affiliation: Synta Pharmaceuticals Corp, Lexington, Massachusetts, United States of America

    X
  • James G. Krueger

    Affiliation: Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, United States of America

    X
  • Published: April 06, 2012
  • DOI: 10.1371/journal.pone.0035069

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.